EIF4E and cancer: For example, a recent prospective study found that >60% of TNBC patients have tumors with high levels of eIF4E, with the conclusion that TNBC patients with high eIF4E overexpression are more likely to recur and die from cancer recurrence and that high eIF4E seems to be a significant prognostic marker in TNBC patients [15].